Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Citadel Group Director's Dealing 2022

Dec 12, 2022

10454_mrq_2022-12-12_aaa06c73-6ba2-4657-9d77-68a992aa5e06.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 4221J

Citadel Group

12 December 2022

Ap 19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.         KEY INFORMATION

Name of person dealing (Note 1) Citadel Group
Company dealt in HORIZON THERAPEUTICS PLC
Class of relevant security to which the dealings being disclosed relate (Note 2) Common Stock ISIN IE00BQPVQZ61
Date of dealing 09 December, 2022

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security

dealt in (Note 3)

Long Short
ISIN IE00BQPVQZ61 Number        (%) Number      (%)
(1) Relevant securities 2,736,312 (1.20%) 155,116 (0.06%)
(2) Derivatives (other than options) 0 (0.00%) 0 (0.00%)
(3) Options and agreements to purchase/sell 339,276 (0.14%) 157,861 (0.06%)
Total 3,075,588 (1.35%) 312,977 (0.13%)

Ap 20

1.         DEALINGS (Note 4)

(a)        Purchases and sales

Purchase/sale

ISIN IE00BQPVQZ61
Number of securities Price per unit (Note 5)
Buy Transaction 13,279 97.2900 USD
Buy Transaction 3,379 97.2900 USD
Buy Transaction 700 97.2900 USD
Buy Transaction 2,255 97.3399 USD
Buy Transaction 744 97.2970 USD
Buy Transaction 56 97.2900 USD
Buy Transaction 6,466 97.2900 USD
Buy Transaction 800 97.3325 USD
Buy Transaction 100 97.5800 USD
Buy Transaction 2,855 97.2008 USD
Buy Transaction 400 97.3225 USD
Sell Transaction 700 97.2900 USD
Sell Transaction 45,930 97.3212 USD
Sell Transaction 8,763 97.1855 USD
Sell Transaction 283 97.2328 USD
Sell Transaction 4,184 97.1963 USD
Sell Transaction 6,933 97.3921 USD
Sell Transaction 21,691 97.3341 USD
Sell Transaction 35,555 97.3763 USD
Sell Transaction 100 97.2800 USD
Sell Transaction 198 97.3324 USD
Sell Transaction 200 97.0400 USD
Sell Transaction 249 97.2498 USD
Sell Transaction 500 97.1680 USD
Sell Transaction 1,275 97.2844 USD
Sell Transaction 1,661 97.3451 USD
Sell Transaction 20 97.5400 USD
Sell Transaction 133 97.2328 USD
Sell Transaction 3,255 97.2328 USD
DVP Transaction 200 97.2900 USD
DVP Transaction 700 97.2900 USD
DVP Transaction 700 97.2900 USD
DVP Transaction 1,200 97.2900 USD
DVP Transaction 3,379 97.2900 USD
DVP Transaction 3,500 97.2900 USD
DVP Transaction 13,279 97.2900 USD
RVP Transaction 13,279 97.2900 USD
RVP Transaction 4,079 97.2900 USD
RVP Transaction 3,500 97.2900 USD
RVP Transaction 1,200 97.2900 USD
RVP Transaction 700 97.2900 USD
RVP Transaction 200 97.2900 USD

(b)        Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

ISIN IE00BQPVQZ61
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c)        Options transactions in respect of existing relevant securities

(i)         Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing,

varying etc.
Number of securities to which the option relates (Note 7) Exercise price Type,

e.g. American, European etc.
Expiry date Option money paid/ received per unit

(Note 5)
Call Option Buy Transaction 54 100.0000 DOL.C-USAA Amer Opt 16/12/2022 2.5000 USD
Call Option Buy Transaction 30 100.0000 DOL.C-USAA Amer Opt 16/12/2022 2.6000 USD
Call Option Buy Transaction 69 100.0000 DOL.C-USAA Amer Opt 16/12/2022 2.6500 USD

(ii)        Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit

(Note 5)

(d)        Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

      (if applicable) (Note 5)

Ap 21

2.         OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated
None

Is a Supplemental Form 8 attached? (Note 9)

NO

Date of disclosure: 12 December, 2022
Contact name: Paula Sharp
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEEALAAFFLAFFA